Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Gary, Dubin"'
Autor:
Dan Bi, Dan Apter, Tiina Eriksson, Mari Hokkanen, Julia Zima, Silvia Damaso, Maaria Soila, Gary Dubin, Matti Lehtinen, Frank Struyf
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 6, Pp 1392-1403 (2020)
This manuscript discloses end-of-study safety data of a community-randomized controlled trial in Finland (NCT00534638), assessing the effectiveness of two vaccination strategies (gender-neutral versus females only) using the AS04-adjuvanted human pap
Externí odkaz:
https://doaj.org/article/3791954e68524bfea031649056a69d4e
Autor:
Tino F. Schwarz, Li-Min Huang, Alejandra Valencia, Falko Panzer, Cheng-Hsun Chiu, Annabelle Decreux, Sylviane Poncelet, Naveen Karkada, Nicolas Folschweiller, Lan Lin, Gary Dubin, Frank Struyf
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 7-8, Pp 1970-1979 (2019)
This study assessed long-term immunogenicity and safety following 3 doses of AS04-adjuvanted human papillomavirus (HPV)-16/18 L1 virus-like particle (VLP) vaccine in females 10–14 years old. Girls included in the immunogenicity subset in the primar
Externí odkaz:
https://doaj.org/article/12db5ea015de4256acac886bf78b7c59
Autor:
Dominique Rosillon, Laurence Baril, Maria Rowena Del Rosario‐Raymundo, Cosette Marie Wheeler, Susan Rachel Skinner, Suzanne Marie Garland, Jorge Salmeron, Eduardo Lazcano‐Ponce, Carlos Santiago Vallejos, Tanya Stoney, Bram ter Harmsel, Timothy Yong Kuei Lim, Swee Chong Quek, Galina Minkina, Shelly Ann McNeil, Celine Bouchard, Kah Leng Fong, Deborah Money, Arunachalam Ilancheran, Alevtina Savicheva, Margaret Cruickshank, Archana Chatterjee, Alison Fiander, Mark Martens, Marie Cecile Bozonnat, Frank Struyf, Gary Dubin, Xavier Castellsagué
Publikováno v:
Cancer Medicine, Vol 8, Iss 10, Pp 4938-4953 (2019)
Abstract Background Infections with human papillomavirus (HPV) types 16 and 18 account for ~70% of invasive cervical cancers but the degree of protection from naturally acquired anti‐HPV antibodies is uncertain. We examined the risk of HPV infectio
Externí odkaz:
https://doaj.org/article/40e9a77e561148afa8859397e1b7d125
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 1, Pp 237-244 (2017)
In 2010, porcine circovirus type 1 (PCV1) material was unexpectedly detected in the oral live-attenuated human rotavirus (RV) vaccine, Rotarix™ (GSK Vaccines, Belgium). An initial study (NCT01511133) found no immunologic response against PCV1 in 40
Externí odkaz:
https://doaj.org/article/f04090e835134f7aa042602bbce8a969
Autor:
Camilo J Acosta, Clemente Diaz, Francesco Nordio, Htay-Htay Han, Kelley J Moss, Kelly Bohning, Pradeep Kumar, Mengya Liu, Hetal Patel, Filippo Pacciarini, Vincent Mwangi, Elke Walter, Tim D Powell, Hana M El Sahly, Whitney R Baldwin, Joseph Santangelo, Evan J Anderson, Gary Dubin
Publikováno v:
The Journal of infectious diseases.
Background We report 2-year persistence of immune response to Takeda's prophylactic purified formalin-inactivated whole Zika virus vaccine candidate (TAK-426) compared with that observed after natural infection. Methods A randomized, observer-blind,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc41af49b6fc99a458571f2193c83228
https://pubmed.ncbi.nlm.nih.gov/36484441
https://pubmed.ncbi.nlm.nih.gov/36484441
Autor:
Silvia Damaso, Tiina Eriksson, Matti Lehtinen, Dan Bi, Dan Apter, Julia Zima, Mari Hokkanen, Frank Struyf, Gary Dubin, Maaria Soila
Publikováno v:
Human Vaccines & Immunotherapeutics
article-version (VoR) Version of Record
article-version (VoR) Version of Record
This manuscript discloses end-of-study safety data of a community-randomized controlled trial in Finland (NCT00534638), assessing the effectiveness of two vaccination strategies (gender-neutral versus females only) using the AS04-adjuvanted human pap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7ce8632308ca0f0ef25476136c9f10d
https://doi.org/10.1080/21645515.2019.1692557
https://doi.org/10.1080/21645515.2019.1692557
Autor:
Maria Rowena Del Rosario-Raymundo, Gary Dubin, Céline Bouchard, Jorge Salmerón, Margaret E. Cruickshank, Frank Struyf, Tanya Stoney, Shelly A. McNeil, Xavier Castellsagué, Marie Cecile Bozonnat, Alison Fiander, Galina Minkina, Bram ter Harmsel, Alevtina Savicheva, Suzanne M. Garland, Deborah Money, Arunachalam Ilancheran, Mark G. Martens, Carlos S. Vallejos, Dominique Rosillon, Timothy Yong Kuei Lim, Kah Leng Fong, Cosette M. Wheeler, S R Skinner, Eduardo Lazcano-Ponce, Laurence Baril, Archana Chatterjee, Swee Chong Quek
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 8, Iss 10, Pp 4938-4953 (2019)
Cancer Medicine, Vol 8, Iss 10, Pp 4938-4953 (2019)
Background Infections with human papillomavirus (HPV) types 16 and 18 account for ~70% of invasive cervical cancers but the degree of protection from naturally acquired anti‐HPV antibodies is uncertain. We examined the risk of HPV infections as def
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::451f2b0014145d37aa1aae80df96e8a9
https://doi.org/10.1002/cam4.1879
https://doi.org/10.1002/cam4.1879
Autor:
Tiina Eriksson, Anna Söderlund-Strand, Geoff P. Garnett, Matti Lehtinen, Ville Pimenoff, Simopekka Vänskä, Joakim Dillner, Eero Pukkala, Kari Natunen, Tapio Luostarinen, Iacopo Baussano, Jorma Paavonen, Gary Dubin, Dan Apter, Pekka Nieminen
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Universidad de Barcelona
Background Human papillomavirus (HPV) vaccination of girls with very high (>90%) coverage has the potential to eradicate oncogenic HPVs, but such high coverage is hard to achieve. However, the herd effect (HE) depends both on the HPV type and the vac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1542270c37a8c04ec5f9dfab2a44964d
http://hdl.handle.net/2445/173415
http://hdl.handle.net/2445/173415
Autor:
Heljä-Marja Surcel, Marjo Kuortti, Eero Pukkala, Tiina Petäjä, Kari Natunen, Katja Harjula, Tiina Eriksson, Mari Siitari-Mattila, Gary Dubin, Mari Hokkanen, Simopekka Vänskä, Pekka Nieminen, Jorma Paavonen, Leena Tuomivaara, Tapio Luostarinen, Anna Söderlund-Strand, Iacopo Baussano, Joakim Dillner, Matti Lehtinen, Sirpa Rekonen, Johanna Palmroth, Geoff P. Garnett, Dan Apter
Publikováno v:
International Journal of Cancer. 143:2299-2310
With optimal strategy, human papillomavirus (HPV) vaccines have the potential to control HPV. We have assessed vaccine efficacy (VE), herd effect (HE) of HPV vaccination and overall protective effectiveness (PE) against high-risk HPV infections by HP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd9599f4819ea83f6a4bc70c2364ce0d
https://doi.org/10.1002/ijc.31618
https://doi.org/10.1002/ijc.31618
Autor:
Kari Natunen, Joakim Dillner, Matti Lehtinen, Tiina Eriksson, Simopekka Vänskä, Eero Pukkala, Geoff P. Garnett, Tapio Luostarinen, Penelope Gray, Dan Apter, Anna Söderlund-Strand, Gary Dubin, Jorma Paavonen, Marko Merikukka, Ville Pimenoff, Johanna Palmroth
Publikováno v:
International Journal of Cancer. 142:2491-2500
Efficacy of human papillomavirus (HPV) vaccines promises to control HPV infections. However, HPV vaccination programs may lay bare an ecological niche for non-vaccine HPV types. We evaluated type-replacement by HPV type and vaccination strategy in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ccc8b0b1e2a1ace0c406630b0f7d662
https://doi.org/10.1002/ijc.31281
https://doi.org/10.1002/ijc.31281